Session: Neonatal-Perinatal Health Care Delivery 2: Health Services Research
Cost-effectiveness of Rapid Whole-Genomic Sequencing Compared with Targeted Neonatal Gene Panel in Infants with a Suspected Genetic Disorder
Saturday, May 4, 2024
8:45 AM – 9:00 AM ET
Location: Metro Toronto Convention Centre: 201 BD
Publication Number: 2165.4
Tara A.. Lavelle, Tufts Medical Center, Boston, MA, United States; Ching-Hsuan Lin, Tufts Childrens Hospital, Boston, MA, United States; Jonathan M. Davis, Tufts University School of Medicine, Boston, MA, United States; Yingying Zhu, Tufts Medical Center, Boston, MA, United States; Stephen F. Kingsmore, Rad, San Diego, CA, United States; Ekwu B. ochigbo, Tufts Childrens Hospital, Longmeadow, MA, United States; Jill L.. Maron, Women & Infants Hospital of Rhode Island, Providence, RI, United States
Presenting Author(s)
Tara A. Lavelle, PhD (she/her/hers)
Assistant Professor Tufts Medical Center Boston, Massachusetts, United States
Disclosure(s):
Tara A. Lavelle, PhD: Genentech (Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator); Merck & Co. (Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator); Takeda (Terminated, October 5, 2023) (Products/Services: Consultant)